ADMA Biologics Inc. (ADMA)
NASDAQ: ADMA
· Real-Time Price · USD
23.64
-0.16 (-0.67%)
At close: May 01, 2025, 2:50 PM
ADMA Biologics Revenue
ADMA Biologics reported an annual revenue of $426.45M, reflecting a 65.15% growth. For the quarter ending December 31, 2024, ADMA Biologics generated $117.55M in revenue.
Revenue (ttm)
$426.45M
Revenue Growth
65.15%
Price / Sales Ratio
9.37
Revenue / Employee
$622.56K
Employees
685
Market Cap
5.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 426.45M | +65.15% |
| Dec 31, 2023 | 258.21M | +67.59% |
| Dec 31, 2022 | 154.08M | +90.36% |
| Dec 31, 2021 | 80.94M | +91.72% |
| Dec 31, 2020 | 42.22M | n/a |